Artivion Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning. Thanks for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson and I lead the medtech and diagnostics equity research team at Needham & Company. With me is Artivion's EVP, COO, and CFO, Ashley Lee. Instead of a standard presentation, we're going to do a Q&A session. If you do have any questions you would like to ask, you can submit them electronically through the Needham conference website or you can feel free to e-mail them to me at [email protected], and I'll do my best to fit them in.
So with that, we're going to get started with the questions unless, Ashley, you'd like to make any sort of an introductory comments?
No, I mean, the only thing that I'll say is as we enter into 2023, it's really the first time in four years where we're operating in an almost nearly normal environment. So we're very optimistic as -- about our business as we move into 2023.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |